National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 4) – specification under subsection 84AAA(2) (No. PB 60 of 2014) (Cth)

PB 60 of 2014

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 4) – specification under subsection 84AAA(2)

National Health Act 1953

I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 14 July 2014

PAUL CREECH

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)   This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 4) – specification under subsection 84AAA(2).

(2)   This Instrument may also be cited as PB 60 of 2014.

2          Commencement

This Instrument commences on 1 August 2014.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

[1]  Schedule 1, after entry for Aciclovir

insert:

Aclidinium Powder for oral inhalation in breath actuated device containing aclidinium bromide 400 micrograms per dose, 60 doses Inhalation by mouth 1 5

[2]  Schedule 1, after entry for Balsalazide

insert:

Betaine Oral powder 180 g Oral 1 5